Theravance Biopharma, Inc. Quarterly Preferred Stock, Shares Authorized from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
Theravance Biopharma, Inc. quarterly Preferred Stock, Shares Authorized history and growth rate from Q4 2013 to Q2 2024.
  • Theravance Biopharma, Inc. Preferred Stock, Shares Authorized for the quarter ending June 30, 2024 was 230K shares, unchanged year-over-year.
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 230K 0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 230K 0 0% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 230K 0 0% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 230K 0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 230K 0 0% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 230K 0 0% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 230K 0 0% Dec 31, 2022 10-K 2024-03-01
Q3 2022 230K 0 0% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 230K 0 0% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 230K 0 0% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 230K 0 0% Dec 31, 2021 10-K 2023-03-01
Q3 2021 230K 0 0% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 230K 0 0% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 230K 0 0% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 230K 0 0% Dec 31, 2020 10-K 2022-02-28
Q3 2020 230K 0 0% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 230K 0 0% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 230K 0 0% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 230K 0 0% Dec 31, 2019 10-K 2021-02-26
Q3 2019 230K 0 0% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 230K 0 0% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 230K 0 0% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 230K 0 0% Dec 31, 2018 10-K 2020-02-27
Q3 2018 230K 0 0% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 230K 0 0% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 230K 0 0% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 230K 0 0% Dec 31, 2017 10-K 2019-02-28
Q3 2017 230K 0 0% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 230K 0 0% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 230K 0 0% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 230K 0 0% Dec 31, 2016 10-K 2018-02-28
Q3 2016 230K 0 0% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 230K 0 0% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 230K 0 0% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 230K 0 0% Dec 31, 2015 10-K 2017-03-01
Q3 2015 230K 0 0% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 230K 0 0% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 230K Mar 31, 2015 10-Q 2015-05-13
Q4 2014 230K +230K Dec 31, 2014 10-K 2016-03-11
Q3 2014 230K Sep 30, 2014 10-Q 2014-11-12
Q2 2014 230K Jun 30, 2014 10-Q 2014-08-14
Q4 2013 0 Dec 31, 2013 10-K 2015-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.